



The present thesis describes work undertaken to determine the role of the ArgP 
protein in E. coli physiology. Primarily, the project was initiated because of two previous 
findings from this laboratory, namely (i) the gltBD argP double mutant is 
(osmo)sensitive to hyperosmotic stress induced by high concentrations of NaCl in the 
growth medium (Nandineni et al., 2004); and (ii) ArgP is a transcriptional regulator of 
the arginine (Arg) exporter, argO (Nandineni and Gowrishankar, 2004; Laishram and 
Gowrishankar, 2007). 
Bacteria, when under hyperosmotic stress, accumulate glutamate (Glu) 
intracellularly through increased synthesis; Glu serves as a counter-ion for K
+
, which also 
accumulates under these conditions (Csonka, 1989; Csonka and Epstein, 1996). In E. 
coli, gltBD encodes Glu synthase, which catalyzes one of the two pathways of Glu 
synthesis. The second pathway is catalyzed by Glu dehydrogenase (GDH) encoded by 
gdhA. The osmosensitive gltBD argP strain showed reduced intracellular levels of Glu 
and GDH compared to a gltBD single mutant in both low and high osmolarity conditions 
(Nandineni et al., 2004). Therefore, it was suggested that the osmosensitivity of the 
gltBD argP strain is because of limited Glu and that ArgP has a role in osmoregulation 
through regulation of gdhA (Nandineni et al., 2004). 
ArgO (previously designated as YggA) is one of the few amino acid exporters 
that have been reported in E. coli. It is an Arg exporter and shares highest sequence 
similarity with LysE of Corynebacterium glutamicum which mediates both Arg and 
lysine (Lys) export. LysE is under transcriptional control of LysG, a protein that shares 
sequence similarity with E. coli ArgP. Both Arg and Lys, through LysG, serve as 
inducers of lysE expression (Bellmann et al., 2001). In vivo studies with argO-lac fusions 
have established that argO is also under the transcriptional control of ArgP and that its 
expression is induced by Arg as well as by its toxic analog canavanine (CAN). However, 
unlike the situation with C. glutamicum LysE, argO expression is repressed in the 
presence of Lys. Dominant gain-of-function mutations in argP (argP
d
), that confer 
elevated, Arg independent argO expression and thereby a CAN resistant phenotype 
(CAN
r
) were also identified (Nandineni and Gowrishankar, 2004). In vitro studies 
showed that ArgP in presence of either co-effectors, Arg or Lys, can recruit RNA 
polymerase (RNAP) to the argO promoter. This then presents two different scenarios, 
productive transcription in the former but a trapped RNAP and no transcription in the 
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latter (Laishram and Gowrishankar, 2007).   
Additionally, there have been various reports from other laboratories on ArgP 
function in E. coli. Arthur Kornberg’s group previously described ArgP as an inhibitor of 
chromosomal initiation (IciA). IciA was shown to bind the AT-rich, conserved 13-mers 
at oriC preventing opening of this region and thereby blocking chromosomal initiation of 
replication (Hwang and Kornberg, 1990, 1992; Thony et al., 1991). Subsequently, IciA 
was reported to be a transcriptional activator of dnaA and nrdA (Lee et al., 1997; Han et 
al., 1998), genes known to have roles in chromosomal replication and DNA synthesis 
respectively. Interestingly, however, the iciA mutant shows no growth or replication 
related phenotype (Thony et al., 1991). In yet other studies, IciA is reported as a nucleoid 
protein (Azam and Ishihama, 1999) that exhibits affinity for AT-rich and curved DNA 
sequences (Wei and Bernander, 1996; Azam and Ishihama, 1999). Recently ArgP was 
described as a transcriptional activator of the genes dapB (encoding an enzyme of the 
Lys biosynthetic pathway) in E. coli and gdhA in Klebsiella aerogenes. The co-effector 
Arg does not have any effect on expression of these genes; Lys represses expression and 
this is through its prevention of ArgP binding to the operator (Bouvier et al., 2008; Goss 
et al., 2008). Accordingly, this thesis describes studies that were undertaken to 
understand ArgP’s role in E. coli physiology and the mechanism of its function. 
To test the hypothesis that ArgP’s role in osmoregulation is through regulation of 
GDH and hence Glu levels in the cell, the effect of ArgP on gdhA-lac expression in vivo 
and ArgP binding in vitro to the gdhA upstream regulatory region were determined. 
Three lines of evidence were obtained to substantiate the same hypothesis:  (i) activation 
by ArgP of gdhA-lac transcription in vivo in a Lys-sensitive manner which clearly 
correlated with the manner of ArgP binding to the cis regulatory region in vitro; (ii) 
osmosensitive phenotype of two strains namely, gltBD argP+ on supplementation with 
Lys, and gltBD argPd-P274S (harboring the argPd allele that is argP-like w.r.t. gdhA-
lac expression); and (iii) the ability of multicopy gdhA
+
 to relieve the osmosensitive 
phenotype of the gltBD argP double mutant strain. Primer extension analysis and site 
directed mutagenesis also enabled the precise location of the functional and ArgP-
regulated gdhA promoter corresponding to a transcription start site that was mapped at 
63-bp upstream of the initiation codon of gdhA. 
To investigate the role of ArgP as a transcriptional activator, data obtained from a 
whole genome differential gene expression microarray along with genes shortlisted using 
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a candidate gene approach (of genes repressed in the presence of Lys), were examined. 
Validation of ArgP regulation of the shortlisted genes was achieved through in vivo 




 and argP strain backgrounds; 
electrophoretic mobility shift assays (EMSAs) of genes showing in vivo ArgP activation 
were also performed. 
The microarray experiment revealed that lysP, the gene encoding a protein with 
the dual functions of a Lys-specific permease and a repressor of the Lys decarboxylase 
system, is a potential regulatory target of ArgP. The argP mutation behaved like lysP 
in conferring thialysine (toxic analog of Lys) resistance. Subsequent experiments showed 
that ArgP activates lysP by about 35-fold in vivo and that there is about 5-fold ArgP-
dependent repression in presence of Lys. In vitro ArgP bound the lysP regulatory region, 
and similar to the findings at gdhA (and dapB), the binding affinity was diminished upon 
Lys addition. Furthermore, sequences of the lysP regulatory region between 114 and 
76 (relative to the start site of transcription) were shown to carry important determinants 
for ArgP binding and regulation. 
The argP mutant did not phenocopy a lysP mutant for expression of the Lys 
decarboxylase system (encoded by the cadBA operon) suggesting that the basal levels of 
LysP in a argP strain is sufficient for the negative regulation of cadBA in absence of 
Lys.  
Compared to the wild-type allele, the argP
d
 mutations showed varying in vivo 
effects on lysP-lac expression. A conspicuous difference was presented by argP
d
-P274S, 
which showed much less activation then argP
+
 and 3-fold Lys repression. 
Concomitantly, EMSAs showed no significant differences in binding affinities. On the 
other hand, differences in mobility of the protein-DNA complexes formed by native 
ArgP and the ArgP
d
 variants were seen, such that the ArgP
d
-DNA complexes migrated 
faster than native ArgP-DNA complex. Such differences in mobility of protein-DNA 
complexes have been reported to be due to differences in DNA bending such that less 
bent DNA migrates faster (Wu and Crothers, 1984). It was thus proposed that the 
differences in ArgP
d
 regulation at lysP might be due to differences in bending of the 
regulatory DNA region.  
Two other genes shortlisted from the microarray data as probable ArgP targets 
were lysC and asd, which encode enzymes of the Lys biosynthetic pathway. Using the 
candidate gene approach, dapD and lysA, also encoding enzymes of the Lys biosynthetic 
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pathway were further examined for ArgP regulation. lysC, asd, dapD and lysA were 
shown to be activated by ArgP to varying extents in vivo (2- to 4-fold). This activation 
was independent of the co-effector Arg but was Lys-sensitive. The argP
d 
variants used in 
this study behaved much like the argP
+ 
allele both for activation and Lys repression at 
these four loci. However, allele -P274S was again different from the others in that it 
behaved more like the ΔargP mutation; this effect was therefore strikingly different from 
its effect at argO where it activates by 270-fold. EMSA showed Lys-sensitive binding of 
ArgP to the regulatory regions of lysC, asd, dapD and lysA, suggesting that Lys 
repression is due to inability of the activator to bind to these operators. These results 
emphasized the fact that the mechanism of ArgP regulation at argO is fundamentally 
different from that at the other regulated loci. First, argO is the only gene that requires 
Arg as co-effector for its activation. Second, the -P274S variant of ArgP is by far the 
most effective for constitutive argO expression, whereas it behaves much like ΔargP for 
a majority of other target genes. Finally, ArgP binding to the cis regulatory region is Lys-
insensitive at argO whereas it is Lys-sensitive at all other target regulatory loci. 
Thereafter, the previously reported findings of ArgP activation of dnaA and nrdA 





argP for dnaA-lac or nrdA-lac expression suggesting that ArgP does not regulate their 
transcription in vivo. However, in conformity with reports from other groups, in vitro 
binding of ArgP to the regulatory regions of dnaA and nrdA with moderate affinity was 
observed. This binding was Lys-insensitive. 
The role of ArgP in the expression of the arginine uptake genes (artP, artJ, hisJ 
and argT) was also assessed. Results showed that ArgP does not regulate Arg import in 
E. coli. Similar to findings at dnaA and nrdA, ArgP showed weak affinity, Lys-
insensitive binding to the regulatory regions of genes encoding Arg uptake.  
To examine if ArgP binds DNA non-specifically, an internal (from the coding 
region) lacZ DNA fragment was used in EMSA reactions. Negligible binding was 
noticed, lending support to the conclusion that ArgP does not bind DNA non-specifically. 
These studies permitted the conclusion that with the exception of argO (which showed 
Lys-insensitive, high affinity binding), a distinguishing feature between in vivo ArgP 
regulated and non-regulated genes was Lys-sensitive binding in vitro. 
 As previously mentioned, the protein-gene pairs ArgP-argO of E. coli and LysG-
lysE of C. glutamicum are orthologous. Whereas LysE is an exporter of Arg and Lys 
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whose expression is induced by Arg, Lys, or histidine (His), ArgO exports Arg alone, 
and its expression is activated by Arg but not Lys or His. In an attempt to understand the 
inter-relationship between these orthologous pairs, transcriptional cross-regulation 
studies were performed. Consequently, reconstitution of activation of lysE by LysG in 
the presence of its co-effectors in E. coli was achieved. It was shown that neither ArgP 
nor LysG can regulate expression of the noncognate orthologous target. Of several ArgP
d
 
variants, some namely ArgP
d 
-P274S, -S94L and to a lesser extent, -P108S activated lysE 
expression in E. coli. However, the individual activating effects of LysG and ArgP
d 
on 
lysE were mutually extinguished when both proteins were coexpressed in Arg- or His-
supplemented cultures. In comparison with native ArgP, the active ArgP
d 
variants 
exhibited higher affinity of binding to the lysE regulatory region and less DNA bending 
at both argO and lysE. These findings led to the conclusions that the transcription factor 
LysG from a Gram-positive bacterium, C. glutamicum, is able to engage appropriately 
with the RNAP from a Gram-negative bacterium, E. coli, for activation of its cognate 
target lysE in vivo and that single-amino-acid-substitution variants of ArgP can also 
activate the distantly orthologous target lysE, but by a subtly different mechanism that 
renders them non-interchangeable with LysG. 
The chapter-wise organization of this thesis describing the studies and findings 
summarized above is as follows: 
Chapter 1 introduces topics related to this thesis and is organized into 4 sections 
describing, physiology of Arg and Lys metabolism in E. coli, ArgP as a transcriptional 
regulator in E. coli, LysG-lysE of C. glutamicum and finally the objectives addressed are 
listed. 
Chapter 2 provides a description of experimental materials and methods used in this 
study. 
Chapter 3 describes experiments performed to examine ArgP’s role in osmoregulation 
through its regulation of gdhA. 
Chapter 4 details results from the microarray experiment and ArgP regulation of the 
Lys-specific permease, lysP. The entire list of genes that showed at least 2-fold activation 
or 2-fold repression by ArgP
(d) 
in the microarray experiment are also listed in Appendix I 
and Appendix II respectively. 
Chapter 5 is an account of ArgP regulation of genes lysC, asd, dapD and lysA each 
encoding enzymes of the Lys biosynthetic pathway. 
Chapter 6 revisits the previous findings of ArgP regulation of genes involved in DNA 
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replication or metabolism and Arg uptake. Results as presented in this chapter suggest 
that ArgP is a non-canonical transcriptional regulator that binds upstream regulatory sites 
without a regulatory outcome. 
Chapter 7 details the transcriptional cross-regulation studies between orthologous 
regulator-target gene pairs ArgP-argO of E. coli and LysG-lysE of C. glutamicum. 
Chapter 8 provides a brief statement of the conclusions from this study and the future 
perspectives. 
 
